Bill > A4938

Introduced Session

This bill provides health care practitioners the discretion to determine which medical conditions would qualify a patient for the use of medical cannabis. Under current law, a patient may only be authorized for the medical use of cannabis when the patient receives authorization from a health care practitioner, who is treating the patient's qualifying medical condition. Current law defines a "qualifying medical condition" to mean a seizure disorder, including epilepsy; intractable skeletal muscular spasticity; post-traumatic stress disorder; glaucoma; positive status for human immunodeficiency virus; acquired immune deficiency syndrome; cancer; amyotrophic lateral sclerosis; multiple sclerosis; muscular dystrophy; inflammatory bowel disease, including Crohn's disease; terminal illness, if the patient has a prognosis of less than 12 months of life; anxiety; migraine; Tourette's syndrome; dysmenorrhea; chronic pain; opioid use disorder; or any other medical condition or its treatment that is approved by the Cannabis Regulatory Commission. This bill amends the requirements under the Jake Honig Compassionate Use Medical Cannabis Act and expands the statutory definition of "qualifying medical condition" to include any other medical condition or disease for which a healthcare practitioner determines that a patient would receive palliative or therapeutic benefit from the use of medical cannabis.

AI Summary

Committee Categories

Reginald Atkins (D)*, 

Introduced, Referred to Assembly Oversight, Reform and Federal Relations Committee (on 10/21/2024)

Official Document